Maida Marcello, Dahiya Dushyant Singh, Shah Yash R, Tiwari Angad, Gopakumar Harishankar, Vohra Ishaan, Khan Aqsa, Jaber Fouad, Ramai Daryl, Facciorusso Antonio
Department of Medicine and Surgery, University of Enna 'Kore', 94100 Enna, Italy.
Division of Gastroenterology, Hepatology and Motility, The University of Kansas School of Medicine, Kansas City, KS 66160, USA.
Cancers (Basel). 2024 Aug 1;16(15):2746. doi: 10.3390/cancers16152746.
Colorectal cancer (CRC) has the highest mortality rate among men and is the second highest among women under fifty, with incidence and mortality rates rising in younger populations. Studies indicate that up to one-third of patients diagnosed before fifty have a family history or genetic factors, highlighting the need for earlier screening. Contrariwise, diagnosis in healthy subjects through screening strategies enables early-stage detection of the tumor and better clinical outcomes. In recent years, mortality rates of CRC in Western countries have been on a steady decline, which is largely attributed to widespread screening programs and advancements in treatment modalities. Indeed, early detection through screening significantly improves prognosis, with stark differences in survival rates between localized and metastatic disease. This article aims to provide a comprehensive review of the existing literature, delving into the performance and efficacy of various CRC screening strategies. It navigates through available screening tools, evaluating their efficacy and cost-effectiveness. The discussion extends to delineating target populations for screening, emphasizing the importance of tailored approaches for individuals at heightened risk.
结直肠癌(CRC)在男性中死亡率最高,在50岁以下女性中排第二高,且在年轻人群中的发病率和死亡率都在上升。研究表明,在50岁之前被诊断出的患者中,高达三分之一有家族病史或遗传因素,这凸显了早期筛查的必要性。相反,通过筛查策略在健康受试者中进行诊断能够实现肿瘤的早期检测并带来更好的临床结果。近年来,西方国家结直肠癌的死亡率一直在稳步下降,这在很大程度上归功于广泛的筛查计划和治疗方式的进步。事实上,通过筛查进行早期检测能显著改善预后,局部疾病和转移性疾病的生存率存在显著差异。本文旨在对现有文献进行全面综述,深入探讨各种结直肠癌筛查策略的性能和效果。它梳理了可用的筛查工具,评估其效果和成本效益。讨论还延伸到确定筛查的目标人群,强调针对高危个体采取量身定制方法的重要性。